z-logo
open-access-imgOpen Access
Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus
Author(s) -
Michael P. Doyle,
Joseph Genualdi,
Adam L. Bailey,
Nurgun Kose,
Christopher Gainza,
Jessica Rodríguez,
Kristen M. Reeder,
Christopher A. Nelson,
Prashant N. Jethva,
Rachel E. Sutton,
Robin G. Bombardi,
Michael L. Gross,
Justin G. Julander,
Daved H. Fremont,
Michael Diamond,
James E. Crowe
Publication year - 2022
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.00512-22
Subject(s) - virology , isolation (microbiology) , monoclonal antibody , virus , neutralizing antibody , antibody , yellow fever , biology , medicine , immunology , microbiology and biotechnology
Yellow fever virus (YFV) is a mosquito-borne virus that occasionally causes outbreaks of severe infection and disease in South America and sub-Saharan Africa. There are very effective live-attenuated (weakened) yellow fever virus vaccines, but recent problems with their production and distribution have left many people in affected areas vulnerable.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom